Tricida, Inc. (TCDA) financial statements (2021 and earlier)

Company profile

Business Address 7000 SHORELINE COURT, SUITE 201
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments30832239421924126155
Cash and cash equivalents19302522371556
Short-term investments28929236919720410550
Other undisclosed current assets5553322
Total current assets:31332739922224426357
Noncurrent Assets
Operating lease, right-of-use asset9102 
Property, plant and equipment3221111
Long-term investments and receivables474111 2  
Long-term investments474111 2  
Deferred costs   1  6
Other undisclosed noncurrent assets   2   
Total noncurrent assets:5953154418
TOTAL ASSETS:37238041422624826465
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39202726152126
Accounts payable64558611
Accrued liabilities3316222161414
Debt111    
Other undisclosed current liabilities   1   
Total current liabilities:40212827152126
Noncurrent Liabilities
Long-term debt and lease obligation67473837382525
Long-term debt, excluding current maturities58383737382525
Operating lease, liability991 
Liabilities, other than long-term debt10000  
Other liabilities10000  
Other undisclosed noncurrent liabilities   1 (25)(25)
Total noncurrent liabilities:684739393900
Other undisclosed liabilities     2423
Total liabilities:108696765534549
Temporary equity, carrying amount      148
Stockholders' equity
Stockholders' equity attributable to parent264312347161195219(132)
Common stock0000000
Additional paid in capital6336226133913873833
Accumulated other comprehensive income (loss)0010(0)(0)(0)
Accumulated deficit(369)(311)(267)(230)(192)(164)(135)
Total stockholders' equity:264312347161195219(132)
TOTAL LIABILITIES AND EQUITY:37238041422624826465

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Operating expenses(58)(45)(38)(38)(29)(29)(25)
Operating loss:(58)(45)(38)(38)(29)(29)(25)
Nonoperating income
(Other Nonoperating income)
1231211
Interest and debt expense(2)(1)(1)(1)(1)(1)(1)
Loss from continuing operations before income taxes:(58)(44)(37)(38)(28)(29)(25)
Other undisclosed income from continuing operations0      
Net loss available to common stockholders, diluted:(58)(44)(37)(38)(28)(29)(25)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(58)(44)(37)(38)(28)(29)(25)
Comprehensive loss:(58)(44)(37)(38)(28)(29)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)00(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(58)(44)(36)(38)(28)(29)(25)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: